Phase I dose escalation study of Radiotherapy and Durvalumab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL): The RaDD study

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/17/Austin/478 (ERM Project ID: 37924)
NMA SSA Reference Number: SSA/37924/MonH-2018-155894
Monash Health Ref: RES-18-0000-740X
Effective start/end date23/04/1922/04/24


  • clinical trial
  • phase 1 study
  • treatment efficacy